Drug coated balloon versus drug eluting stent in primary percutaneous coronary intervention: a feasibility study. - DCB vs. DES in pPCI: a feasibility study.

Clinical hospital center Rijeka0 个研究点目标入组 75 人开始时间: 2017年2月13日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Inclusion criteria were: 1) STEMI presenting less than 12 hours from symptoms onset; 2) de novo lesion: coronary artery occlusion or critical stenosis; 3) coronary artery diameter from 2.5 to 4.0 mm.

•Exclusion criteria were: 1) stroke within the last six months; 2) likelihood of survival less than one year; 3) pregnancy or breastfeeding; 4) The Modification of Diet in Renal Disease (MDRD) derived eGFR <30 ml/min/1,73 m2; 5) in stent restenosis; 6) extensive coronary disease needing additional revascularization; 7) PCI or coronary artery bypass graft (CABG) surgery within the last six months; 8) severe coronary artery tortuosity; 9) hypersensitivity, allergies and other contraindications to acetylsalicylic acid, clopidogrel, heparin, paclitaxel or eptifibatide; 10) allergies to iodine-containing contrast medium; 11) leucocytes count <3,5 x 10^9/L and platelets count <75 x 10^9/L or >650 x 10^9/L.

发起方

Clinical hospital center Rijeka